Efficacy and Safety of TF002 in Cutaneous Mastocytosis
Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations
A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter
Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis
Natural History of Urticaria Pigmentosa in Children
Mast Cell Connect: A Registry for Patients With Mastocytosis
† Study has passed its completion date and status has not been verified in more than two years.